Journal of Alzheimer's Disease

The Journal of Alzheimer's Disease is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer's disease. The journal publishes research reports, reviews, short communications, hypotheses, ethics reviews, book reviews, and letters-to-the-editor. The journal is dedicated to providing an open forum for original research that will expedite our fundamental understanding of Alzheimer's disease.

Publisher
IOS Press
History
1998-present
Website
http://www.j-alz.com/
Impact factor
3.920 (2016)

Some content from Wikipedia, licensed under CC BY-SA

Alzheimer's disease & dementia

Link between Alzheimer's disease and gut microbiota is confirmed

Alzheimer's disease is the most common cause of dementia. Still incurable, it directly affects nearly one million people in Europe, and indirectly millions of family members as well as society as a whole. In recent years, ...

Neuroscience

Women have more active brains than men

In the largest functional brain imaging study to date, the Amen Clinics (Newport Beach, CA) compared 46,034 brain SPECT (single photon emission computed tomography) imaging studies provided by nine clinics, quantifying differences ...

Alzheimer's disease & dementia

Culprit hidden in plain sight in Alzheimer disease development

A new study by researchers at the University of Montana, Universidad del Valle de México, Instituto Nacional de Pediatría, Boise State, and Universidad Nacional Autónoma de México, heightens concerns over the detrimental ...

Alzheimer's disease & dementia

Simple test can help detect Alzheimer's before dementia signs show

York University researchers say a simple test that combines thinking and movement can help to detect heightened risk for developing Alzheimer's disease in a person, even before there are any telltale behavioural signs of ...

Alzheimer's disease & dementia

Neuroscientists say daily ibuprofen can prevent Alzheimer's disease

A Vancouver-based research team led by Canada's most cited neuroscientist, Dr. Patrick McGeer, has successfully carried out studies suggesting that, if started early enough, a daily regimen of the non-prescription NSAID (nonsteroidal ...

Neuroscience

Three stages to COVID-19 brain damage identified by neurologists

The Journal of Alzheimer's Disease has just published a paper with a comprehensive review of the COVID-19's effect on the nervous system which classifies brain damage caused by COVID-19 into three stages. One of the authors, ...

page 1 from 40